What Bio-Gene Technology does

Bio-Gene Technology Limited (ASX: BGT) is an Australian agtech development company addressing global insecticide resistance through a proprietary beta-triketone chemistry platform derived from Australian native flora. The company's product portfolio comprises two distinct offerings: Flavocide™, a nature-identical beta-triketone molecule (flavesone) produced synthetically and covered by Bio-Gene patents, which is the lead product and has demonstrated activity against insect pests resistant to existing classes; and Qcide™, a natural oil product containing tasmanone as the active constituent, extracted via steam distillation from leaves of a rare cultivar of Gympie Messmate (Eucalyptus cloeziana) grown in plantation systems by sub-contractors in Far Northern Queensland. Both actives share a novel mode of action designed to overcome existing insecticide resistance mechanisms across sucking and chewing pests, with applications spanning crop protection, grain storage, public-health vector control, animal health, and consumer insecticide markets.

Bio-Gene operates as a publicly listed, development-stage company on a partnership-driven commercialization model. The company does not disclose product revenue and is not yet generating material royalty or product income. Its revenue model anticipates income from technology licensing fees, milestone payments tied to development and regulatory achievements, royalties on partner sales, and selective product sales where Bio-Gene controls manufacturing know-how. Bio-Gene retains ownership of intellectual property and aims to secure active-ingredient registrations through the US EPA and Australia's APVMA, while partnering with larger commercial players for downstream formulation, registration stewardship in specific territories, marketing, and distribution. Headquarters are at Level 6, 400 Collins Street, Melbourne, with a small team of 1-10 employees.

The company's commercial ecosystem includes STK Bio-Ag Technologies (a global development and license agreement executed in 2023 for natural insecticide commercialization), Envu (August 2024 partnership targeting Flavocide-based mosquito control), Evergreen Garden Care (consumer-garden product development), Clarke Mosquito Control (public-health product development), CSIRO (research collaboration on Flavocide), the Grains Research & Development Corporation (grain-storage registration support), and the Queensland Government Department of Agriculture and Fisheries (ongoing Flavocide grain-protectant work since 2017). Funding has come from repeated equity placements and share purchase plans (most recently a $3.27 million Placement in June 2025 followed by a partially underwritten SPP) supplemented by US government grants, including a reported $15 million from the US CDC for vector-borne disease applications. IP assets include a granted US patent for Flavocide (March 2023), broader beta-triketone patent coverage, and OMRI organic certification for Qcide under the USDA National Organic Program (November 2025).

Name

Bio-Gene Technology

Legal name

Bio-Gene Technology Limited

Website

https://bio-gene.com.au

Company type

Public

Founded year

1995

Operating status

Operating

Headcount range

1–10 employees

Short description

Bio-Gene Technology (ASX: BGT) is an Australian agtech development company creating novel beta-triketone bio-insecticides (Flavocide™ and Qcide™) derived from Australian native flora, targeting resistance-breaking pest control across crop protection, grain storage, public health, and consumer markets via commercial partnerships.

Ownership category

akta.pro rank

Product category

Bio-insecticides / Crop Protection Chemicals

NAICS

Pesticide and Other Agricultural Chemical Manufacturing (32532)

SIC

Agricultural Chemicals (2870), Industrial Organic Chemicals (2860)

akta.pro primary industry

Crop Protection Chemicals (Herbicides/Insecticides/Fungicides) (IMAEAEAI)

akta.pro secondary industries

Grain Protectants & Post-Harvest Insecticide Application (AFAOAIAF), Natural/Organic Mosquito, Tick & Flea Treatments (HSAMAEAH)

Keywords

• Novel bio-insecticides
• Crop protection chemicals
• Grain storage protectants
• Beta-triketone chemistry
• Public health insecticides

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales

Revenue model

1. Licensing Fees and Royalties: Generate multiple revenue streams from technology licensing fees, milestone payments, and royalties by securing and owning active ingredient product registrations.
2. Milestone Payments: Milestone payments received upon achievement of development and regulatory milestones in partnership agreements.
3. Product Sales: Sales of manufactured product to partners for re-sale, controlling manufacturing and production know-how.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Bio-Gene Technology develops and manufactures two novel bio-insecticides — Flavocide™ (a synthetic nature-identical beta-triketone molecule) and Qcide™ (a natural oil containing tasmanone extracted from Australian eucalypt) — to address global insecticide resistance across crop protection, grain storage, public health, and consumer applications. The company retains ownership of active ingredient registrations and intellectual property while commercializing through partnerships with major market players in multiple geographies.

Product overview

Bio-Gene Technology is an Australian agtech development company that develops novel bio-insecticides based on naturally occurring beta-triketones to address global insecticide resistance. The company's product portfolio consists of two distinct offerings: Flavocide™ (a nature-identical/synthetic beta-triketone molecule produced chemically) and Qcide™ (a natural oil product derived from Australian eucalypt leaves via steam distillation). Both products target insecticide resistance with novel modes of action and have applications across crop protection, grain storage, public health, and consumer markets.

Differentiator

Problem solved

Functional benefit

Brands

• Flavocide™: A nature-identical beta-triketone molecule produced synthetically by a chemical process, covered by Bio-Gene patents for use as an insecticide. It has demonstrated significant activity against a range of insect pests and is the company's lead product candidate.
• Qcide™

Products and services

• Flavocide™

Quantifiable outcome

• 13-month residual control against key grain storage pests including resistant strains
• +2 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• EnvucoreStrategic or Co-development Partner · 14 August 2024Partnership with Envu to tackle mosquitoes with Flavocide technology, announced August 2024.
• Grains Research & Development CorporationminorStrategic or Co-development Partner · 12 May 2023GRDC support to develop, register, and commercialize Flavocide for use in grain storage applications.
• STK Bio-Ag TechnologiescoreStrategic or Co-development Partner · 19 January 2023Bio-Gene executed a development and license agreement with STK Bio-Ag Technologies for global collaboration. This multi-million dollar partnership focuses on developing and commercializing Bio-Gene's natural insecticide technology, with STK providing distribution and market access capabilities.
• Department of Agriculture and Fisheries, Queensland GovernmentcoreStrategic or Co-development Partner · 1 January 2017Ongoing collaboration since 2017 with DAF Queensland to develop Flavocide as a potential grain protectant. Results have demonstrated effective control of key grain storage pests including resistant strains.
• Evergreen Garden CarecoreStrategic or Co-development PartnerCommercial development agreement with Evergreen Garden Care for product development collaboration.
• Clarke Mosquito ControlcoreStrategic or Co-development PartnerCommercial development agreement with Clarke Mosquito Control for mosquito control product development.
• CSIROcoreTechnology or IntegrationResearch collaboration with CSIRO on Flavocide development, including work on taking the new insecticide from leaf to lab.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Vestaron Corporation: Vestaron develops peptide-based bioinsecticides targeting resistant pests in agriculture. Both companies are small, pre-commercial or early-commercial developers of novel-mode-of-action bioinsecticides, using partnership-driven commercialization across crop protection markets.
• AgBiTech: AgBiTech develops and commercializes baculovirus-based biological insecticides for crop protection globally. Both firms target resistant insect pests in agricultural markets using biologically derived active ingredients with novel modes of action.
• Certis Biologicals: Certis Biologicals is a leader in biological-based crop protection products including microbial and botanical insecticides. Both Bio-Gene and Certis serve the demand for naturally-derived, softer-chemistry insecticides addressing resistance and residue concerns.
• McLaughlin Gormley King (MGK): MGK manufactures natural pyrethrum-based and botanical insecticides for consumer, public health, and crop protection markets. Both companies develop nature-derived insect control actives with applications across consumer, vector control, and agricultural segments.

Emerging players

• Oxitec: Oxitec develops mosquito control technologies to suppress populations of disease vectors such as Aedes aegypti. Both address the resistance crisis in mosquito/vector control with novel biologically-derived solutions targeting public health agencies.

Broad incumbents

• FMC Corporation: FMC is a major global agricultural sciences company with a broad crop protection insecticide portfolio, including diamide chemistries addressing resistant pests. Comparable as a potential commercialization partner or competitor within Bio-Gene's crop protection target markets.
• Sumitomo Chemical: Sumitomo Chemical operates a global crop protection and animal health insecticide business, including metaflumizone and other novel chemistries. A potential commercial partner and direct competitor in segments where Bio-Gene targets resistant pests.
• Bayer Crop Science: Bayer Crop Science is one of the largest global producers of crop protection insecticides and vector control products (e.g., neonicotinoids). Bio-Gene competes for the same end-markets and partner channels Bayer addresses, with a differentiated bioinsecticide.
• Syngenta: Syngenta is a global agrochemical major with a broad insecticide portfolio across crop protection, seed treatment, and grain storage. Comparable as a potential commercialization partner and dominant competitor in Bio-Gene's target insecticide markets.
• BASF Agricultural Solutions: BASF's Agricultural Solutions division develops and markets insecticides, including novel modes of action for resistant pest management. Directly comparable to Bio-Gene in insecticides addressing resistance, with a much broader portfolio and partner footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• Xx.com/biogenetechltd
• LinkedInlinkedin.com/company/bio-gene-technology

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bio-Gene Technology